BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -18.57%134.05M | 29.66%164.04M | 32.87%97.87M | -1.10%130.95M | 84.92%164.61M | -3.54%126.51M | -41.29%73.66M | -5.42%132.41M | -63.86%89.02M | -23.63%131.16M |
Transactional financial assets | --0.03 | 0.00%0.03 | ---- | ---- | ---- | -100.00%0.03 | -72.18%1.22M | --5.24M | --7.99M | --24.25M |
Notes receivable and accounts receivable | 27.68%381.97M | 19.85%321.26M | 13.47%353.06M | 11.64%332.75M | 7.34%299.16M | 3.03%268.05M | 20.49%311.14M | 22.60%298.06M | 27.40%278.71M | 52.44%260.16M |
-Notes receivable | 259.67%48.17M | 33.81%34.59M | -43.02%16.97M | -56.39%15.77M | -64.66%13.39M | -34.72%25.85M | 99.58%29.79M | 295.20%36.16M | 364.51%37.9M | 173.28%39.6M |
-Accounts receivable | 16.81%333.8M | 18.36%286.67M | 19.46%336.09M | 21.03%316.98M | 18.67%285.76M | 9.81%242.2M | 15.64%281.35M | 11.94%261.9M | 14.34%240.81M | 41.22%220.57M |
Other receivables (including interest and dividends) | 136.39%8.47M | 187.95%8.77M | 23.41%3.8M | 35.66%4.55M | -17.37%3.58M | -63.26%3.05M | -9.48%3.08M | -58.78%3.35M | -60.77%4.33M | -35.68%8.29M |
-Other receivable | ---- | 187.95%8.77M | ---- | 35.66%4.55M | ---- | -63.26%3.05M | ---- | -58.78%3.35M | ---- | -35.68%8.29M |
Advance payment | 62.52%10.12M | -30.79%4.9M | -39.86%9.5M | -7.92%12.41M | -66.39%6.23M | 11.95%7.08M | 22.95%15.8M | 99.06%13.48M | 98.34%18.53M | -29.09%6.33M |
Inventories | 0.01%294.27M | 3.90%258.38M | 10.41%279.99M | 11.57%275.15M | 24.56%294.23M | 18.65%248.68M | 4.43%253.59M | -3.13%246.61M | 5.26%236.21M | 13.24%209.6M |
Receivable financing | 354.25%4.29M | -37.92%8.53M | -9.33%5.25M | 21.14%8.37M | -89.78%945.47K | -23.69%13.73M | -61.03%5.79M | -62.02%6.91M | 55.01%9.25M | 815.87%18M |
Other current assets | 7.06%52.52M | -13.47%42.62M | -22.73%34.44M | -30.92%28.16M | 18.61%49.06M | 21.22%49.26M | 8.99%44.57M | -10.80%40.76M | -31.26%41.36M | -33.74%40.64M |
Total current assets | 8.31%885.8M | 12.85%808.5M | 10.59%784.15M | 6.09%792.34M | 19.28%817.82M | 2.58%716.43M | 0.87%709.04M | 4.24%746.83M | -11.65%685.63M | 14.00%698.42M |
Non Current assets | ||||||||||
Other equity investment | -2.91%78.32M | -2.91%78.32M | 56.65%80.67M | 95.54%80.67M | 95.54%80.67M | 388.81%80.67M | 300.57%51.49M | 306.22%41.25M | 476.55%41.25M | 214.03%16.5M |
Investment real estate | -3.47%484.73K | -3.43%489.07K | -89.90%493.42K | -89.93%497.76K | -93.24%502.17K | -90.10%506.45K | -5.49%4.89M | -5.49%4.94M | 40.50%7.42M | -4.16%5.12M |
Fixed assets | ---- | 15.25%685.65M | ---- | 28.83%677.11M | ---- | 10.14%594.94M | ---- | 26.23%525.59M | ---- | 43.48%540.19M |
Constru in process | ---- | 105.13%317.49M | ---- | -13.20%125.58M | ---- | 120.48%154.77M | ---- | 5.87%144.68M | ---- | -50.10%70.2M |
Intangible assets | 54.45%144.13M | 54.58%145.32M | 38.93%131.57M | 9.87%104.79M | -2.84%93.32M | -2.78%94.01M | -2.56%94.7M | -2.13%95.37M | -1.99%96.05M | -1.16%96.7M |
Long deferred expense | 29.81%11.45M | 38.23%11.75M | 38.00%11.63M | 13.09%10.48M | -8.27%8.82M | -14.35%8.5M | 0.49%8.43M | 34.33%9.26M | 72.06%9.62M | 81.27%9.93M |
Deferred tax assets | -56.46%993.94K | -49.35%1.18M | -88.65%1.93M | -90.10%1.89M | -89.48%2.28M | -90.10%2.33M | 243.97%17.03M | 338.67%19.09M | 373.92%21.7M | 342.87%23.57M |
Usufruct assets | 95.39%5.75M | 102.14%6.44M | 75.85%7.08M | 73.57%7.59M | -31.96%2.94M | 36.19%3.19M | 62.90%4.03M | 0.81%4.37M | -4.20%4.33M | -50.33%2.34M |
Other non current assets | -51.96%57.71M | 30.88%78.51M | 281.28%131.18M | 233.02%109.15M | 230.55%120.13M | 75.34%59.98M | 16.73%34.41M | 20.15%32.78M | 103.62%36.34M | 42.51%34.21M |
Total non current assets | 30.98%1.38B | 32.66%1.33B | 31.89%1.22B | 27.40%1.12B | 25.31%1.06B | 25.06%998.9M | 25.71%928.08M | 23.36%877.33M | 22.59%843.66M | 19.65%798.75M |
Total assets | 21.10%2.27B | 24.39%2.13B | 22.67%2.01B | 17.60%1.91B | 22.61%1.88B | 14.57%1.72B | 13.59%1.64B | 13.77%1.62B | 4.44%1.53B | 16.95%1.5B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | -16.79%199.26M | 36.73%219.35M | 68.01%252.2M | 59.43%227.58M | 130.80%239.47M | 149.26%160.42M | 88.40%150.11M | 2.64%142.75M | -47.10%103.76M | -70.45%64.36M |
Notes payable and accounts payable | 15.31%124.72M | 13.14%124.53M | 16.56%107.07M | 19.28%113.16M | 38.21%108.16M | 29.64%110.07M | 24.62%91.85M | 47.05%94.87M | -7.80%78.26M | -0.24%84.91M |
-Notes payable | 5.79%20.44M | 69.41%11M | 610.54%4.8M | 75.39%15.3M | 75.20%19.32M | 7.17%6.49M | -95.09%675K | 336.05%8.72M | --11.03M | --6.06M |
-Accounts payable | 17.39%104.29M | 9.61%113.53M | 12.16%102.27M | 13.60%97.86M | 32.14%88.84M | 31.36%103.58M | 52.08%91.18M | 37.80%86.15M | -20.79%67.23M | -7.36%78.85M |
Contract liabilities | -64.07%4.08M | 64.00%9.69M | -22.78%6.07M | 19.21%6.77M | 115.03%11.35M | 29.44%5.91M | 141.73%7.86M | 41.77%5.68M | 77.81%5.28M | -53.17%4.56M |
Salaries payable | -4.63%11.57M | 5.01%22.33M | 88.47%20.18M | -34.72%12.24M | -2.05%12.13M | -7.13%21.27M | -1.19%10.71M | 89.30%18.75M | 29.92%12.38M | 16.50%22.9M |
Taxs payable | 119.88%7.18M | 11.67%3.22M | -12.32%1.9M | -57.69%2.17M | -43.76%3.27M | 4.34%2.89M | -45.88%2.16M | 0.16%5.13M | 119.95%5.81M | -54.62%2.77M |
Other payable (including interest and dividends) | 16.09%2.68M | 13.86%3.08M | 41.47%2.69M | 853.54%20.5M | 35.51%2.31M | 71.50%2.71M | 21.34%1.9M | -11.55%2.15M | -66.56%1.7M | -62.73%1.58M |
-Dividend payable | ---- | ---- | ---- | --18.07M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other payable | ---- | 13.86%3.08M | ---- | 12.90%2.43M | ---- | 71.50%2.71M | ---- | -11.55%2.15M | ---- | -62.73%1.58M |
Non current liabilities due within one year | 29.37%110.29M | 11.68%97.96M | 105.52%97.56M | 295.35%65.7M | 357.41%85.26M | 81.67%87.72M | -4.23%47.47M | -57.33%16.62M | -63.96%18.64M | -24.08%48.28M |
Other current liabilities | -29.05%22.83M | -42.59%19.15M | -49.98%16.93M | -51.35%13.99M | 8.23%32.18M | 1.06%33.36M | 7.22%33.85M | -16.99%28.75M | -16.57%29.73M | 2.78%33.01M |
Total current liabilities | -2.28%482.83M | 17.75%499.66M | 45.76%504.6M | 46.87%462.57M | 93.35%494.11M | 61.53%424.33M | 34.10%346.18M | 3.38%314.96M | -34.24%255.55M | -40.07%262.69M |
Current liabilities | ||||||||||
Long term account payable | ---- | ---- | ---- | ---- | ---- | -61.12%1.16M | ---- | -62.89%2.21M | ---- | -73.91%3M |
Deferred tax liabilities | 47.20%27.09M | 74.30%27.98M | -16.96%24.78M | -27.39%21.73M | -32.63%18.4M | -44.84%16.05M | 67.53%29.83M | 81.28%29.92M | 96.52%27.32M | 95.14%29.11M |
Long term deferred income | -11.07%51.48M | -11.06%52.69M | 7.91%56.87M | 7.50%56.92M | 56.58%57.88M | 57.98%59.24M | 80.19%52.7M | 294.20%52.95M | 450.02%36.97M | 389.94%37.5M |
Lease liabilities | 69.07%3.32M | 94.05%3.77M | 35.97%4.42M | 53.40%5M | -35.96%1.97M | -12.89%1.94M | 39.26%3.25M | 28.20%3.26M | 13.88%3.07M | -16.38%2.23M |
Total non current liabilities | 115.73%619.24M | 136.21%473.35M | 60.73%387.36M | 30.36%359.01M | 20.41%287.05M | -10.54%200.39M | 17.29%241.01M | 75.04%275.4M | 139.15%238.39M | -12.03%224M |
Total liabilities | 41.08%1.1B | 55.75%973.01M | 51.90%891.96M | 39.17%821.58M | 58.15%781.15M | 28.36%624.73M | 26.65%587.19M | 27.78%590.36M | 1.16%493.94M | -29.77%486.69M |
Shareholders equity | ||||||||||
Paid-in capital | 29.88%727.34M | 29.88%727.34M | 29.88%727.34M | 0.00%560.01M | 40.00%560.01M | 40.00%560.01M | 40.00%560.01M | 40.00%560.01M | 0.00%400.01M | 11.11%400.01M |
Capital reserve funds | -77.48%48.1M | -77.76%47.5M | -77.95%47.23M | 0.04%214.31M | -42.92%213.62M | -42.92%213.62M | -42.75%214.23M | -42.73%214.23M | 0.05%374.24M | 554.88%374.24M |
Surplus reserve funds | 57.96%45.04M | 57.96%45.04M | 28.04%28.51M | 28.04%28.51M | 28.04%28.51M | 28.04%28.51M | 30.33%22.27M | 30.33%22.27M | 30.33%22.27M | 30.33%22.27M |
Retained profit | 13.26%313.55M | 22.97%310.22M | 25.10%285.93M | 23.89%263.6M | 29.51%276.85M | 31.27%252.28M | 28.65%228.57M | 24.14%212.76M | 17.10%213.77M | 27.03%192.19M |
Less:Treasury stock | 0.00%24.93M | 763.25%24.93M | --24.93M | --24.93M | --24.93M | --2.89M | ---- | ---- | ---- | ---- |
Other composite income | 138.31%7.44M | 137.54%7.53M | 60.06%6.35M | -52.34%1.83M | -22.32%3.12M | -15.76%3.17M | 445.86%3.97M | 429.19%3.85M | 453.28%4.02M | 417.99%3.76M |
Specific reserves | -38.34%1.09M | -73.12%326.3K | 66.19%2.18M | 13.48%2.21M | -10.50%1.76M | -14.68%1.21M | -24.13%1.31M | 29.31%1.95M | 42.74%1.97M | 139.03%1.42M |
Shareholders equity without minority interests | 5.54%1.12B | 5.41%1.11B | 4.10%1.07B | 3.00%1.05B | 4.20%1.06B | 6.24%1.06B | 6.06%1.03B | 5.21%1.02B | 4.15%1.02B | 69.36%993.89M |
Minority interests | 45.64%50.9M | 37.29%47.6M | 123.13%43.66M | 129.27%42.96M | 83.21%34.95M | 108.97%34.67M | 220.59%19.57M | 2,077.46%18.74M | 13,600.10%19.08M | 4,408.12%16.59M |
Total shareholder equity | 6.82%1.17B | 6.42%1.16B | 6.32%1.12B | 5.29%1.09B | 5.65%1.09B | 7.93%1.09B | 7.40%1.05B | 7.06%1.03B | 6.09%1.04B | 72.08%1.01B |
Total liabilityies and equity | 21.10%2.27B | 24.39%2.13B | 22.67%2.01B | 17.60%1.91B | 22.61%1.88B | 14.57%1.72B | 13.59%1.64B | 13.77%1.62B | 4.44%1.53B | 16.95%1.5B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified opinion | -- | -- | -- | -- |
Auditor | -- | -- | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.